PARKVIEW SURGERY — All Prescriptions & Medications — Page 2
Practice Code: E83028 | EDGWARE, HA8 0RW
Showing results 51-100 of 446
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Felodipine | 406 | 12.2K | £2.0K | -31.6% ▼ |
| Candesartan cilexetil | 402 | 16.6K | £822 | -66.1% ▼ |
| Levetiracetam | 390 | 19.6K | £1.3K | -14.8% ▼ |
| Rosuvastatin calcium | 386 | 17.3K | £663 | -57.0% ▼ |
| Folic acid | 376 | 17.6K | £377 | -71.0% ▼ |
| Hydrocortisone | 376 | 11.5K | £1.8K | -16.1% ▼ |
| Spironolactone | 367 | 8,125 | £971 | -31.9% ▼ |
| Isosorbide mononitrate | 367 | 8,864 | £1.3K | -44.5% ▼ |
| Allopurinol | 367 | 18.9K | £417 | -64.4% ▼ |
| Montelukast | 365 | 10.7K | £511 | -46.7% ▼ |
| Alendronic acid | 365 | 2,176 | £490 | -51.3% ▼ |
| Risperidone | 355 | 7,248 | £1.2K | +40.3% ▲ |
| Prednisolone | 339 | 18.2K | £2.1K | -57.6% ▼ |
| Buprenorphine | 333 | 1,468 | £5.5K | -9.1% ▼ |
| Perindopril erbumine | 327 | 14.1K | £1.2K | -38.4% ▼ |
| Sodium valproate | 317 | 51.1K | £4.4K | -0.3% vs avg |
| Quetiapine | 316 | 11.7K | £3.6K | -49.2% ▼ |
| Lamotrigine | 316 | 9,086 | £441 | -46.5% ▼ |
| 307 | 34.7K | £922 | +11.0% ▲ | |
| Venlafaxine | 306 | 9,781 | £2.0K | -63.8% ▼ |
| Procyclidine hydrochloride | 270 | 4,718 | £206 | +90.9% ▲ |
| Olanzapine | 268 | 4,767 | £509 | -27.7% ▼ |
| Carbocisteine | 254 | 41.2K | £1.1K | -52.4% ▼ |
| Ferrous fumarate | 251 | 10.6K | £399 | -65.4% ▼ |
| Melatonin | 250 | 19.5K | £2.3K | -24.8% ▼ |
| Atenolol | 249 | 10.9K | £241 | -58.7% ▼ |
| Sildenafil (Erectile Dysfunction) | 236 | 1,780 | £246 | -53.2% ▼ |
| Tiotropium bromide | 232 | 3,832 | £7.7K | -23.7% ▼ |
| Macrogol 3350 | 230 | 33.3K | £2.0K | -75.5% ▼ |
| Linagliptin | 227 | 3,920 | £4.4K | -44.6% ▼ |
| Oxycodone hydrochloride | 226 | 15.8K | £4.5K | -11.7% ▼ |
| Bendroflumethiazide | 225 | 11.9K | £192 | -70.9% ▼ |
| Senna | 221 | 9,990 | £229 | -63.3% ▼ |
| Hydroxocobalamin | 219 | 227 | £486 | -54.5% ▼ |
| Insulin aspart | 213 | 1,284 | £8.7K | -44.1% ▼ |
| Betamethasone valerate | 212 | 17.8K | £887 | -44.9% ▼ |
| Diltiazem hydrochloride | 210 | 8,342 | £1.4K | -31.6% ▼ |
| 209 | 469 | £16.0K | -61.7% ▼ | |
| Lisinopril | 208 | 3,206 | £86 | -81.0% ▼ |
| Flucloxacillin sodium | 207 | 8,388 | £508 | -54.0% ▼ |
| Cetirizine hydrochloride | 205 | 14.4K | £726 | -59.0% ▼ |
| Mometasone furoate | 200 | 15.1K | £1.4K | +49.6% ▲ |
| Oxybutynin | 194 | 7,980 | £385 | +1.8% vs avg |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 193 | 205 | £2.9K | +70.2% ▲ |
| Nebivolol | 191 | 4,004 | £1.9K | +80.2% ▲ |
| Doxycycline hyclate | 190 | 2,277 | £218 | -62.9% ▼ |
| Duloxetine hydrochloride | 187 | 1,806 | £143 | -70.6% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 185 | 18.3K | £824 | +3.0% ▲ |
| Prochlorperazine maleate | 179 | 7,811 | £426 | -11.4% ▼ |
| 175 | 21.2K | £893 | -63.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.